Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
HTML
PDF
Details
Locations
Year:
2013
Type:
review
Source:
The AAPS Journal
DOI:
10.1208/s12248-013-9470-x
Authors:
Thomayant Prueksaritanont,
Xiaoyan Chu,
Christopher Gibson,
Donghui Cui,
Ka Lai Yee,
Jeanine Ballard,
Tamara Cabalu,
Jerome Hochman
show all 8
Institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
Language:
English
Topic:
Pharmacogenetics and Drug Metabolism
Subfield:
Pharmacology
Field:
Pharmacology, Toxicology and Pharmaceutics
Domain:
Life Sciences
Keywords:
drug-drug interactions,
regulatory guidelines,
FDA guidance for industry,
drug transporters,
time-dependent inhibition,
enzyme induction,
enzyme inhibition,
model-based prediction,
early drug development,
in vitro and in vivo studies
show all 10
SDG:
Good health and well-being
Open Access status:
bronze
OpenAlex ID:
W2005998697
FWCI:
2.683
Cites:
89
Cited by:
274
Related to:
10